Joint Formulary & PAD

Macrogol compound - Constipation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Sachets (powder)
Associated Icons :
Restrictions / Comments :
Important
Prescribe as macrogol compound oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
 

Status 2

Red
Formulations :
  • Sachets (powder)
Associated Icons :
Restrictions / Comments :
Important
Moviprep / Plenvu - ADULTS only. Off-label use. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Macrogol compound
Indication :
Constipation
Group Name :
Keywords :
laxatives
Brand Names Include :
Laxido, Movicol, Cosmocol, Macilax, Molaxole, Strigol, Moviprep, Plenvu
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Macrogol compound is used to treat.

Committee Recommendations (2)

The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.

Management | Constipation | CKS | NICE

The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.

Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.

GENERIC macrogol compound has been considered by the APC and has been assigned a GREEN traffic light status.

NOTE - the branded product, Movicol, was considered NON-FORMULARY at the APC in May 2017